Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPembroke Vct Regulatory News (PEMB)

Share Price Information for Pembroke Vct (PEMB)

Share Price is delayed by 15 minutes
Get Live Data
92.00    0.00 (0.00%)
Bid:
90.00
Ask:
94.00
Spread: 4.00 (4.444%)
Market Cap: £269.20m
PEMB Live PriceLast checked at - London Stock Exchange

Intraday Pembroke Vct Share Chart

Publication of Prospectus

9 Sep 2024 12:03

RNS Number : 4499D
Pembroke VCT PLC
09 September 2024
 

9 September 2024

 

Pembroke VCT plc

 

 

Publication of Prospectus

 

Pembroke VCT plc (the "Company") has today published a prospectus (the "Prospectus") in relation to the offer for subscription of up to £40 million of B Ordinary Shares of 1p each in the capital of the Company with an over-allotment facility for up to a further £20 million of B Ordinary Shares (the "Offer"). 

 

The deadline for the receipt of applications is 12 noon on 4 April 2025 in respect of the 2024/2025 tax year and 3.00 p.m. on 27 June 2025 in respect of the 2025/2026 tax year, or as soon as the Offer is fully subscribed. The closing date of the Offer, and the deadline for receipt of applications for the final allotment with respect to the 2025/2026 tax year, may be extended by the Directors at their absolute discretion to a date no later than 3 September 2025.

 

An application has been made for the admission of the further B Ordinary Shares to be issued under the Offer to a listing on the FCA's Official List and to trading on the main market of the London Stock Exchange. It is expected that new B Ordinary Shares will be issued throughout the period of the Offer until it closes.

 

Pursuant to an offer agreement dated 9 September 2024 relating to the Offer between, among others, the Company and Pembroke Investment Managers LLP ("PIM"), PIM, as promoter of the Offer, will receive a fee calculated on the value of each application for B Ordinary Shares under the Offer accepted by the Company as follows:

 

(i) 5.0% for investors who have invested directly into the Company or invested through an intermediary/platform and have not received advice;

(ii) 3.0% for investors who have invested in the Offer through an intermediary and have received upfront advice including investors who are investing through intermediaries/advisers using financial platforms,

or such lower percentage in each case as may be agreed by the Company and PIM.

 

As PIM is the Company's investment manager, PIM is a related party of the Company under the UK Listing Rules and the payment of the above fee by the Company to PIM is a related party transaction falling within UK Listing Rule 8.2.1R.

 

A copy of the Prospectus is available, free of charge, from the registered office of the Company at 3 Cadogan Gate, London, SW1X 0AS.

 

A copy of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website:

 

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

 

For further information, please contact:

 

Andrew Wolfson / Chris Lewis

Pembroke Investment Managers LLP (Manager)

+44 20 7766 6900

 

Robin Smeaton

The City Partnership (UK) Limited (Company Secretary)

enquiries@city.uk.com

 

Keith Lassman

Howard Kennedy Corporate Services LLP

keith.lassman@howardkennedy.com 

 

Seven Hills

Leigh Marshall

M: +44 7388 003595

E: pembroke@wearesevenhills.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIUKRARSUUKRAR
Date   Source Headline
30th Jun 20269:00 amRNSNotification of Admission of Shares and TVR
26th Jun 20264:00 pmRNSIntention to Launch an Offer for Subscription
26th Jun 20263:31 pmRNSAnnual Financial Report
29th May 20264:00 pmRNSTotal Voting Rights
29th May 202610:30 amRNSIssue of Equity
28th May 202612:30 pmRNSNotification of Admission of Shares
11th May 20267:00 amRNSClose of Offer to Further Applications
30th Apr 20264:00 pmRNSNotification of Admission of Shares and TVR
30th Apr 202610:30 amRNSIssue of Equity
22nd Apr 20261:00 pmRNSPurchase of Own Securities
10th Apr 202612:10 pmRNSIssue of Equity
31st Mar 20261:30 pmRNSTotal Voting Rights
31st Mar 20261:05 pmRNSUtilisation of over-allotment facility
31st Mar 20269:00 amRNSIssue of Equity
6th Mar 202611:16 amRNSDirector/PDMR Shareholding
6th Mar 202611:15 amRNSDirector/PDMR Shareholding
6th Mar 202611:12 amRNSDirector/PDMR Shareholding
5th Mar 202610:07 amRNSIssue of Equity
27th Feb 20269:00 amRNSNotification of Admission of Shares and TVR
13th Feb 20269:00 amRNSIssue of Equity
11th Feb 20261:09 pmRNSNet Asset Value
30th Jan 20267:00 amRNSNotification of Admission of Shares and TVR
20th Jan 20269:00 amRNSIssue of Equity
13th Jan 20267:00 amRNSDirectorate change
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
16th Dec 20252:15 pmRNSIssue of Equity and TVR
28th Nov 20257:00 amRNSTotal Voting Rights
21st Nov 20259:16 amRNSDirector/PDMR Shareholding
21st Nov 20259:15 amRNSDirector/PDMR Shareholding
21st Nov 20259:00 amRNSIssue of Equity
17th Nov 20253:15 pmRNSHalf-Year Report
13th Nov 202510:29 amRNSChange of Registered Office
12th Nov 20254:44 pmRNSDividend Declaration
23rd Oct 202512:25 pmRNSIssue of Equity and TVR
25th Sep 20255:42 pmRNSResult of AGM
19th Sep 20255:19 pmRNSPurchase of Own Securities
9th Sep 20253:51 pmRNSPublication of Prospectus
21st Aug 202510:40 amRNSNet Asset Value per Share as at 30 June 2025
25th Jun 20252:15 pmRNSAnnual Financial Report - Replacement
25th Jun 202512:51 pmRNSIntention to Launch an Offer for Subscription
25th Jun 202512:47 pmRNSAnnual Financial Report
27th May 202512:07 pmRNSIssue of Equity
24th Apr 20252:35 pmRNSIssue of Equity
15th Apr 20255:46 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSIssue of Equity
31st Mar 20256:10 pmRNSIssue of Equity
20th Mar 202512:19 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.